SERVICES
-
Oncology commercial & development strategy
-
Investor & BD pitch presentations
-
C-Suite & decision-maker presentations
-
Commercial operations Integration plans
-
Market differentiation, impact & value analysis and presentation
-
-
Companion diagnostics & precision medicine strategy
-
Key Business Questions for Drug development early Discovery
-
3-5 year CDx Launch-plan templates
-
-
Portfolio and lifecycle management
-
Strategic Input into drug development and competitive clinical trial design
-
-
Acquisition leads
-
Seed funding support
-
Partnership & deal structures
Clinical and R&D productivity remains a grand challenge impacting both big pharma and hospitals
Approaching the right partners in the right way and at the right time is key for the growth and success of small and medium sized business.
With the XBI down 22.7% for 2023, the bear market in biotech continues due to continued concerns regarding inflation and rates. However, the roughly 1/3rd reduction in Pharma ROI will have to be offset – most likely leaning onto digital dexterity and integrating AI tool and external alliance.
The winners are likely the ones who understand the critical pain pitons, how to their offerings fit and how to strike the right partnership.
Prioritizing which functional groups to approach, and with the right road map is going to be critical in establishing successful partnerships & approvals. Also, Biotech that stay afloat will be the ones with a sustainable plan.
Kronos is here to help you analyze your strategy, prioritize your approach, make meaningful connections and provide you with sustainable templates.
CORE VALUES OFFERED
